Bone marrow findings of patients from prospective study of romiplostim on bone marrow morphology
Patient ID . | Cellularity, percentage . | Megakaryocytes per high power field . | Reticulin grade assessment . | |||
---|---|---|---|---|---|---|
Baseline . | On treatment . | Baseline . | On treatment . | Baseline . | On treatment . | |
11 | 40 | 60 | 5.3 | 10.6 | 0-1 | 1-2 |
12 | 60 | 50 | 5.6 | 8.8 | 0-1 | 0-1 |
13 | 50 | 50 | 7.0 | 5.8 | 0-1 | 1 |
14 | 30 | 25 | 1.7 | 2.7 | 0-1 | 0-1 |
15 | 25 | 50 | 3.0 | 2.7 | 0-1 | 0-1 |
16 | 50 | > 95 | 2.5 | 0.1 | NE | 2 |
5 | 60 | 60 | 12.0 | 21.1 | 0-1 | 0-1 |
17 | 50 | NA | 2.7 | NA | 0-1 | NE |
18 | 50 | 50 | 6.9 | 6.5 | NE | 1 |
19 | 60 | 75 | 3.8 | 12.0 | 0-1 | NE |
Patient ID . | Cellularity, percentage . | Megakaryocytes per high power field . | Reticulin grade assessment . | |||
---|---|---|---|---|---|---|
Baseline . | On treatment . | Baseline . | On treatment . | Baseline . | On treatment . | |
11 | 40 | 60 | 5.3 | 10.6 | 0-1 | 1-2 |
12 | 60 | 50 | 5.6 | 8.8 | 0-1 | 0-1 |
13 | 50 | 50 | 7.0 | 5.8 | 0-1 | 1 |
14 | 30 | 25 | 1.7 | 2.7 | 0-1 | 0-1 |
15 | 25 | 50 | 3.0 | 2.7 | 0-1 | 0-1 |
16 | 50 | > 95 | 2.5 | 0.1 | NE | 2 |
5 | 60 | 60 | 12.0 | 21.1 | 0-1 | 0-1 |
17 | 50 | NA | 2.7 | NA | 0-1 | NE |
18 | 50 | 50 | 6.9 | 6.5 | NE | 1 |
19 | 60 | 75 | 3.8 | 12.0 | 0-1 | NE |
NE indicates specimen not evaluable for reticulin staining; and NA, not available.